Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 may harm male fertility and damage the reproductive system.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 doesn't make alopecia areata worse.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

COVID-19 may cause increased and quicker hair loss compared to other infections.

COVID-19 led to fewer dermatology admissions in Hubei, China, with more severe cases and increased eczema due to mask use and hand disinfectants.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.